Phase I study of safety of morphine for dyspnea in patients with interstitial lung disease - Phase I study of safety of morphine for dyspnea in patients with interstitial lung disease

on-Profit Organization JORTC0 个研究点目标入组 12 人开始时间: 2015年1月6日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients with contraindication of morphine (ex. allergy for morphine and history of severe adverse effects of morphine) 2. Patients who use opioid 3. Patients with left heart failure by echocardiography. 4. Patients with acute respiratory failure ( bacterial pneumonia, acute excerbation of interstitial pneumonia and so on). 5. Patients with active infection that causes dyspnea 6. Patients with lung cancer that causes dyspnea 7. Patients with pneumothorax 8. Patients who uses invasive positive airway pressure ventilation. Patients who uses nasal high flow were not excluded 9. Patients who changed the way of intaking of corticosteroids, immunosuppressant, bronchodilators, vasodilators and anxiolytics within two days before enrollment of the study 10. Patients who have or had drug abuse or drug dependence 11. Patients who are pregnant or possibly pregnant 12. Patients who are judged to be innapropriate for the study by the physician

发起方

on-Profit Organization JORTC